Mitral regurgitation resident survival guide: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Mitral regurgitation is a disorder of the valve of the heart present between the [[left atrium]] and [[left ventricle]].  Blood from the left ventricle enters the left atrium along with [[aorta]], because of the incompetence of the mitral valve (dual outlet left ventricle).
Mitral regurgitation is a disorder of the heart valve that is present between the [[left atrium]] and [[left ventricle]].  Mitral regurgitation is characterized by the incompetence of the mitral valve which fails to completely close during systole. Hence, When the left ventricle contracts and pump blood into the aorta, a certain amount of blood leaks from the left ventricle  into the left atrium (dual outlet left ventricle).


==Classification==
==Classification==
Mitral regurgitation can be acute or chronic. [[Acute mitral regurgitation]] causes sudden overload of the left atrium and left ventricle and can cause pulmonary congestion. [[Chronic mitral regurgitation|Chronic regurgitation]] develops over months to years and in this phase the left ventricle develops eccentric hypertrophy in order to compensate for the pressure changes in the heart and if decompensated the left ventricle enters a dysfunctional phase. Long standing volume overload on the left ventricle causes left ventricle to dysfunction.
Mitral regurgitation can be acute or chronic. [[Acute mitral regurgitation]] causes sudden overload of the left atrium and left ventricle and can cause pulmonary congestion. [[Chronic mitral regurgitation|Chronic regurgitation]] develops over a period of months to years during which the left ventricle undergoes eccentric hypertrophy as a compensatory mechanism for the pressure changes in the heart. Long standing volume overload on the left ventricle results in the inability of the left ventricle to compensate beyond a certain extent and thus leads left ventricle to dysfunction.


==Causes==
==Causes==
Mitral regurgitation (MR) can be caused by either the valve or the ventricle.  
Mitral regurgitation (MR) can be caused either by intrinsic defects in the mitral valve or by defects in the ventricle.


Valvular mitral regurgitation is caused by
*Defects in the mitral valve:
* Degenerative
** Degeneration
** [[Chordal rupture]]
**[[Chordal rupture]]
** [[Infective endocarditis]]
***[[Infective endocarditis]]
** [[Mitral valve prolapse]]
***[[Mitral valve prolapse]]


* [[Rheumatic heart disease]]
** [[Rheumatic heart disease]]


Ventricular cause of mitral regurgitation is otherwise called secondary or functional MR and it is caused by:
*Defects in the ventricle (otherwise called secondary or functional MR):
* [[Dilated cardiomyopathy]]
** [[Dilated cardiomyopathy]]
* [[Ischemic heart disease]]
** [[Ischemic heart disease]]


[[Image:MR_causes.JPG|center|500px]]
[[Image:MR_causes.JPG|center|500px]]
Line 28: Line 28:
==Differentiating Mitral regurgitation from Aortic regurgitation==
==Differentiating Mitral regurgitation from Aortic regurgitation==
[[Image:MR_DD.JPG|center|500px]]
[[Image:MR_DD.JPG|center|500px]]
The [[ejection fraction]] in [[aortic insufficiency]] reflects the state of contractility of left ventricle unlike [[mitral regurgitation]].


==Natural History and Prognosis==
==Natural History and Prognosis==
===Natural History===
===Natural History===
Natural history of mitral regurgitation is dictated by the etiology.
The natural history of mitral regurgitation is dictated by the underlying etiology.
* [[Papillary muscle]] rupture and deihisced mitral valve prosthesis - poor prognosis without surgery.
* [[Papillary muscle]] rupture and deihisced mitral valve prosthesis - there is poor prognosis without surgery.
* [[Endocarditis]] - response to antibiotics decides the natural history and progression of mitral regurgitation.
* [[Endocarditis]] - the natural history and progression of mitral regurgitation depends on the response to the antibiotics.
* Chordal rupture - depends on tolerance of severe MR.
 
Patients with normal left ventricular function and severe acute [[pulmonary edema]] are supposed to have severe MR.


===Prognosis===
===Prognosis===
* Effective regurgitant orifice (ERO) area is a good prognostic indicator of severity of MR and survival. Mortality risk is related directly to the degree of ERO. The higher the area the lower the survival.
* Effective regurgitant orifice (ERO) area is a good prognostic indicator of the severity of the MR and the survival. The mortality risk is related directly to the degree of ERO. The higher the area is, the lower the survival is.
* Untreated severe [[MR]] has a poor prognosis.
* Untreated severe [[MR]] has a poor prognosis.


Line 47: Line 42:


===Symptoms===
===Symptoms===
* [[Acute miral regurgitation]] presents with the following symptoms:
* [[Acute miral regurgitation]] causes the following symptoms:
** [[Dyspnea]]
** [[Dyspnea]]
** [[Orthopnea]]
** [[Orthopnea]]
** [[Hypotension]]
** [[Hypotension]]


* [[Chronic mitral regurgitation]] may have a prolonged asymptomatic interval phase before the heart enters a decompensated phase where the patient may have the symptoms of low cardiac output and pulmonary congestion.  By the time symptoms develop, left ventricular dysfunction may have already occurred.
* [[Chronic mitral regurgitation]] may have a prolonged asymptomatic interval phase until the heart decompensates and the symptoms of low cardiac output and pulmonary congestion start.  By the time symptoms develop, left ventricular dysfunction may have already occurred.


===Physical Examination===
===Physical Examination===
Line 66: Line 61:


===Imaging===
===Imaging===
* [[Transthoracic echocardiography]] (TTE). Three important points that are to be considered while doing an ECHO assessment include:
====[[Transthoracic echocardiography]]====
** How does it affect the left ventricle ?
** What causes it ?
** How much is there ?
 
In mitral valve prolapse the valve leaflets go into the left atrium. Te eccentric jet is away from the abnormal leaflet.


Coaptation in left ventricle jet hugs posteriorly is seen in ischemic mitral regurgitation.
Echocardiographic findings reflecting the severity of the mitral regurgitation include:
 
Echocardiographic findings to quantify the severity of mitral regurgitation include:
* Regurgitant volume - (>60 ml)
* Regurgitant volume - (>60 ml)
* Regurgitant fraction - (>55%)
* Regurgitant fraction - (>55%)
* Effective regurgitant orifice (ERO) (ratio of regurgitant flow volume to the velocity of the mitral insufficiency jet (ERO = Flow / Velocity)) - (>0.4 cm<sup>2</sup>)
* Effective regurgitant orifice (ERO) (ratio of regurgitant flow volume to the velocity of the mitral insufficiency jet (ERO = Flow / Velocity)) - (>0.4 cm<sup>2</sup>)


All the three factors mentioned above are better parameters to quantify severity than color jet area.  
All the three factors mentioned above are better parameters to quantify severity than color jet area.


* If the left ventricular and left atrial sizes are normal on an ECHO mitral regurgitation is not severe.
* If the left ventricular and left atrial sizes are normal on an ECHO mitral regurgitation is not severe.
Line 88: Line 76:
Echocardiographic findings must match the symptoms.
Echocardiographic findings must match the symptoms.


If TTE is negative [[transesophageal echocardiography]] (TEE) or [[cardiac catheterization]] are the preferred diagnostic imaging modalities.  TTE can underestimate the clinical picture in patients with clinical signs of severe and mild MR.  If cath discrepancy is present it is recommended to do a left ventriculogram using 48 cc at 12 cc/sec with no PVCs an left atrium off the spine to assess for mitral regurgitation.
If the TTE is negative [[transesophageal echocardiography]] (TEE) or [[cardiac catheterization]] are the preferred diagnostic imaging modalities.  TTE can underestimate the clinical picture in patients with clinical signs of severe and mild MR.  In case of any discrepancy in the results of different modalities, it is recommended to do a left ventriculogram.
 
==Treatment==
==Treatment==
===Acute severe Mitral regurgitation===
===Acute severe Mitral regurgitation===
Treatment of acute severe mitral regurgitation depends upon the stability of the patient.  
Treatment of acute severe mitral regurgitation depends on the stability of the patient.
 
If the patient is clinically '''stable''', the treatment options are:
If the clinical condition of the patient is '''stable''' the treatment options are:
* IV vasodilators, [[diuretics]], [[antibiotics]], [[anti-ischemic agents]]
* IV vasodilators, [[diuretics]], [[antibiotics]], [[anti-ischemic agents]]
* Surgery is preferred in:
* Surgery is preferred in the following cases:
** [[Endocarditis]] with progressive [[congestive heart failure]]
** [[Endocarditis]] with progressive [[congestive heart failure]]
** No response to antibiotics
** No response to antibiotics
Line 102: Line 88:
** Recurrent [[embolization]]
** Recurrent [[embolization]]


In clinically '''unstable''' patients treatment options include:
If the patient is clinically '''unstable''' , the treatment options are:
* IV [[nitroprusside]] to maintain blood pressure. Ionotropes are added when needed.
* IV [[nitroprusside]] to maintain blood pressure. Ionotropes are added when needed.
* If medical therapy is not effective an [[intra aortic balloon pump]] can be inserted to maintain hemodynamic stability.
* If medical therapy is not effective, an [[intra aortic balloon pump]] can be inserted to maintain hemodynamic stability.
* Surgical treatment is usually indicated.
* Surgical treatment is usually indicated.
 
* Knowledge of the etiology of the [[mitral regurgitation]] is important to know if the valve can be repaired or replaced.
Knowledge about the etiology of [[mitral regurgitation]] is important to know if the valve can be repaired or replaced.


===Chronic Mitral regurgitation===
===Chronic Mitral regurgitation===
* In asymptomatic patients with preserved left ventricular function there is no indication for vasodilator therapy in the absence of [[systemic hypertension]].
* There is no indication for vasodilator therapy in the absence of [[systemic hypertension]] in asymptomatic patients with preserved left ventricular function .


===Indications for surgery in Mitral regurgitation===
===Indications for surgery in Mitral regurgitation===
Line 116: Line 101:
* Severe organic [[MR]].
* Severe organic [[MR]].
* Left ventricular dysfunction - [[ejection fraction]] <60% and [[end systolic diameter]] >40 mm<sup>2</sup>.
* Left ventricular dysfunction - [[ejection fraction]] <60% and [[end systolic diameter]] >40 mm<sup>2</sup>.
*Surgery can be considered in asymptomatic patients in the following cases:
**Truly severe MR
**Low operative mortality
**High chance of successful repair (e.g: posterior leaflet - [[MVP]])


Pre-operative ejection fraction has a prognostic impact in patients who undergo mitral valve repair or replacement.  The lower the ejection fraction the higher the chances or mortality.
Pre-operative ejection fraction has a prognostic impact in patients who undergo mitral valve repair or replacement.  The lower the ejection fraction is, the higher the mortality is.


In asymptomatic patients surgery can be considered if:
* Truly severe MR
* Low operative mortality
* High chance of successful repair (e.g: posterior leaflet - [[MVP]])





Revision as of 15:21, 16 October 2012

Mitral Regurgitation Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Mitral Regurgitation from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

Stages

History and Symptoms

Physical Examination

Chest X Ray

Electrocardiogram

Echocardiography

Cardiac MRI

Cardiac Catheterization

Treatment

Overview

Acute Mitral Regurgitation Treatment

Chronic Mitral Regurgitation Treatment

Surgery

Follow Up

Case Studies

Case #1

Mitral regurgitation resident survival guide On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mitral regurgitation resident survival guide

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMitral regurgitation resident survival guide

CDC on Mitral regurgitation resident survival guide

Mitral regurgitation resident survival guide in the news

Blogs on Mitral regurgitation resident survival guide

Directions to Hospitals Treating Mitral regurgitation

Risk calculators and risk factors for Mitral regurgitation resident survival guide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Mitral regurgitation is a disorder of the heart valve that is present between the left atrium and left ventricle. Mitral regurgitation is characterized by the incompetence of the mitral valve which fails to completely close during systole. Hence, When the left ventricle contracts and pump blood into the aorta, a certain amount of blood leaks from the left ventricle into the left atrium (dual outlet left ventricle).

Classification

Mitral regurgitation can be acute or chronic. Acute mitral regurgitation causes sudden overload of the left atrium and left ventricle and can cause pulmonary congestion. Chronic regurgitation develops over a period of months to years during which the left ventricle undergoes eccentric hypertrophy as a compensatory mechanism for the pressure changes in the heart. Long standing volume overload on the left ventricle results in the inability of the left ventricle to compensate beyond a certain extent and thus leads left ventricle to dysfunction.

Causes

Mitral regurgitation (MR) can be caused either by intrinsic defects in the mitral valve or by defects in the ventricle.

Differentiating Mitral regurgitation from Aortic regurgitation

Natural History and Prognosis

Natural History

The natural history of mitral regurgitation is dictated by the underlying etiology.

  • Papillary muscle rupture and deihisced mitral valve prosthesis - there is poor prognosis without surgery.
  • Endocarditis - the natural history and progression of mitral regurgitation depends on the response to the antibiotics.

Prognosis

  • Effective regurgitant orifice (ERO) area is a good prognostic indicator of the severity of the MR and the survival. The mortality risk is related directly to the degree of ERO. The higher the area is, the lower the survival is.
  • Untreated severe MR has a poor prognosis.

Diagnosis

Symptoms

  • Chronic mitral regurgitation may have a prolonged asymptomatic interval phase until the heart decompensates and the symptoms of low cardiac output and pulmonary congestion start. By the time symptoms develop, left ventricular dysfunction may have already occurred.

Physical Examination

  • S3 and S4 may be heard on auscultation.
  • A holosystolic murmur is heard in the apex region of the heart and radiating to the axilla. MR murmur may be soft, short and even absent. 70% papillary muscle rupture cases have no murmur.
Holosystolic murmur of acute mitral regurgitation.
Holosystolic murmur of chronic mitral regurgitation.

Imaging

Transthoracic echocardiography

Echocardiographic findings reflecting the severity of the mitral regurgitation include:

  • Regurgitant volume - (>60 ml)
  • Regurgitant fraction - (>55%)
  • Effective regurgitant orifice (ERO) (ratio of regurgitant flow volume to the velocity of the mitral insufficiency jet (ERO = Flow / Velocity)) - (>0.4 cm2)

All the three factors mentioned above are better parameters to quantify severity than color jet area.

  • If the left ventricular and left atrial sizes are normal on an ECHO mitral regurgitation is not severe.
  • Central jets indicate normal mitral valve and therefore not severe.
  • Wide eccentric jets indicate that the regurgitation is severe.

Echocardiographic findings must match the symptoms.

If the TTE is negative transesophageal echocardiography (TEE) or cardiac catheterization are the preferred diagnostic imaging modalities. TTE can underestimate the clinical picture in patients with clinical signs of severe and mild MR. In case of any discrepancy in the results of different modalities, it is recommended to do a left ventriculogram.

Treatment

Acute severe Mitral regurgitation

Treatment of acute severe mitral regurgitation depends on the stability of the patient. If the patient is clinically stable, the treatment options are:

If the patient is clinically unstable , the treatment options are:

  • IV nitroprusside to maintain blood pressure. Ionotropes are added when needed.
  • If medical therapy is not effective, an intra aortic balloon pump can be inserted to maintain hemodynamic stability.
  • Surgical treatment is usually indicated.
  • Knowledge of the etiology of the mitral regurgitation is important to know if the valve can be repaired or replaced.

Chronic Mitral regurgitation

  • There is no indication for vasodilator therapy in the absence of systemic hypertension in asymptomatic patients with preserved left ventricular function .

Indications for surgery in Mitral regurgitation

  • Any symptoms - this is unlike mitral stenosis where surgeons operate on the heart when patients have class III or IV symptoms.
  • Severe organic MR.
  • Left ventricular dysfunction - ejection fraction <60% and end systolic diameter >40 mm2.
  • Surgery can be considered in asymptomatic patients in the following cases:
    • Truly severe MR
    • Low operative mortality
    • High chance of successful repair (e.g: posterior leaflet - MVP)

Pre-operative ejection fraction has a prognostic impact in patients who undergo mitral valve repair or replacement. The lower the ejection fraction is, the higher the mortality is.


References

Template:WH Template:WS